Page 36 - Boxed Warning News Today

8 December 2022 Clinigen notes results from the MIROCALS trial investigating low dose Proleukin (aldesleukin) in patients with amyotrophic lateral sclerosis Clinigen Limited

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that data from its robust migraine portfolio will be presented at the 16th European Headache Federation...

The FDA has approved Rezlidhia (olutasidenib) for acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation.

/PRNewswire/ -- Neurelis, Inc., announced the company will present nine posters at the 76th American Epilepsy Society Annual Meeting (AES), December 2 – 6,...

21 scientific presentations, including 7 late breakers, showcase the breadth of UCBs portfolio, reinforcing commitment to improving the lives of people living...

Allergan Aesthetics celebrates two decades of BOTOX® Cosmetic (onabotulinumtoxinA) and continues to drive innovation.

/PRNewswire/ -- Neurelis, Inc., a commercial-stage neuroscience company focused on the development and commercialization of therapeutics for the treatment of...

/PRNewswire/ -- Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical...

Peer-reviewed results from the Phase 3 open-label extension study of FINTEPLA® in LGS provide significant reduction in the frequency of multiple seizure types...

ImmunoGen Appoints Daniel Char as Senior Vice President and Chief Legal Officer - read this article along with other careers information, tips and advice on BioSpace